Patents by Inventor Andrew Anthony WIECZOREK

Andrew Anthony WIECZOREK has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS AND METHODS FOR TREATING HYPERTRIGLYCERIDEMIA
    Publication number: 20230212578
    Abstract: The present invention provides compositions comprising therapeutic nucleic acids such as siRNA that target ApoC3 and ANGPTL3 expression, lipid particles comprising one or more (e.g., a combination) of the therapeutic nucleic acids, and methods of delivering and/or administering the lipid particles (e.g., for treating hypertriglyceridemia in humans).
    Type: Application
    Filed: November 30, 2022
    Publication date: July 6, 2023
    Applicant: ARBUTUS BIOPHARMA CORPORATION
    Inventors: Ting CHIU, Narayanan HARIHARAN, Amy C. H. LEE, Christopher Justin PASETKA, Janet Ruth PHELPS, Nicholas Michael SNEAD, Andrew Anthony WIECZOREK
  • COMPOSITIONS AND METHODS FOR TREATING HYPERTRIGLYCERIDEMIA
    Publication number: 20210047640
    Abstract: The present invention provides compositions comprising therapeutic nucleic acids such as siRNA that target ApoC3 and ANGPTL3 expression, lipid particles comprising one or more (e.g., a combination) of the therapeutic nucleic acids, and methods of delivering and/or administering the lipid particles (e.g., for treating hypertriglyceridemia in humans).
    Type: Application
    Filed: April 16, 2020
    Publication date: February 18, 2021
    Applicant: ARBUTUS BIOPHARMA CORPORATION
    Inventors: Ting CHIU, Narayanan HARIHARAN, Amy C. H. LEE, Christopher Justin PASETKA, Janet Ruth PHELPS, Nicholas Michael SNEAD, Andrew Anthony WIECZOREK
  • COMPOSITIONS AND METHODS FOR TREATING HYPERTRIGLYCERIDEMIA
    Publication number: 20180245077
    Abstract: The present invention provides compositions comprising therapeutic nucleic acids such as siRNA that target ApoC3 and ANGPTL3 expression, lipid particles comprising one or more (e.g., a combination) of the therapeutic nucleic acids, and methods of delivering and/or administering the lipid particles (e.g., for treating hypertriglyceridemia in humans).
    Type: Application
    Filed: March 21, 2016
    Publication date: August 30, 2018
    Applicant: PROTIVA BIOTHERAPEUTICS, INC.
    Inventors: Ting CHIU, Narayanan HARIHARAN, Amy C. H. LEE, Christopher Justin PASETKA, Janet Ruth PHELPS, Nicholas Michael SNEAD, Andrew Anthony WIECZOREK